Síndrome coronario agudo secundario a trastornos de hipercoagulabilidad

Cardiocore - Tập 46 - Trang e17-e19 - 2011
María Rosa Fernández-Olmo1, Javier Torres Llergo1, Manuel Villa Gil-Ortega1, Ángel Sánchez González1
1Servicio de Cardiología, Hospital Universitario Virgen del Rocío, Sevilla, España

Tài liệu tham khảo

Margucci, 2006, PAI-1 and homocysteine, but not lipoprotein(a) and trombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting, Heart., 92, 377, 10.1136/hrt.2005.061895 Spronk, 2004, Blood coagulation and the risk of atherothrombosis: a complex relationship, Thrombosis Journal., 2, 12, 10.1186/1477-9560-2-12 Rodríguez Rodrigo, 2004, Infarto de miocardio y mutación de la enzima 5,10-metilentetrahidrofolato reductasa, Rev Esp Cardiol., 57, 476, 10.1157/13061126 Boekholdt, 2007, Arterial thrombosis and the role of thrombophilia, Semin Thromb Hemost., 6, 588, 10.1055/s-2007-985755 Burzotta, 2004, G20210A Prothrombim gene polymorphism and coronary ischaemic syndromes: a phenotype specific meta-analysis of 12,034 subjects, Heart, 90, 86, 10.1136/heart.90.1.82 Santos, 2004, Trombosis coronaria recurrente, síndrome antifosfolipídico primario, factor V Leiden y virus de la inmunodeficiencia humana, Rev Esp Cardiol., 57, 997, 10.1157/13066462